OrthoTrophix Announces Early Completion of Enrollment in Phase 2b Trial of TPX-100 in Knee Osteoarthritis

OrthoTrophix, Inc., a privately held biopharmaceutical company developing novel investigational therapies for osteoarthritis, today announced the early completion of the planned patient enrollment in ...
Nature

Equine Magnetic Resonance Imaging and Bone Pathology

Recent advances in equine magnetic resonance imaging (MRI) have considerably enhanced the diagnostic evaluation of bone pathology in horses. MRI, in its various presentations from low- to high-field ...
Kaleido Scope

Wei named Hazel Gore, M.B.B.S., Endowed Professor in Women’s Health

Shi Wei, M.D., Ph.D., Division Director, Women’s Health, Section Head, Bone and Soft Tissue Pathology, has been named the Hazel Gore, M.B.B.S., Endowed Professor in ...
Kaleido Scope

Wei named Section Head, Bone and Soft Tissue Pathology

Shi Wei, M.D., Ph.D., Division Director, Women's Health, has been named section head for bone and soft tissue pathology, effective April 1. Wei assumes the position ...